LJL BioSystems of Sunnyvale, Calif., received a patent for its SmartOptics light detection technology, designed for single-nucleotide polymorphism genotyping and drug discovery.
SmartOptics extracts signals from small volume samples, thus allowing scientists to miniaturize assays. This enables greater throughput at lower costs, the company said.
LJL has 65 issued, pending and provisional patents.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
